Abstract
Objective:
The goal of this study was to delineate the epidemiology of echocardiographically diagnosed pulmonary hypertension (PH) in extremely low birth weight (ELBW) infants with bronchopulmonary dysplasia (BPD) requiring prolonged positive pressure ventilation (PPV), and to determine the independent relationship between PH and mortality in these patients.
Study Design:
Our retrospective cohort included ELBW infants, with BPD requiring prolonged PPV, hospitalized in Cincinnati, Ohio during 2003–2009, as recorded in the National Institute of Child Health and Human Development Neonatal Research Network Database. Following chart review, a logistic regression model was constructed to understand the contribution of PH to mortality in infants with BPD requiring prolonged PPV.
Result:
We identified 216 patients (19%) with BPD requiring prolonged PPV among 1156 ELBW infants. Of these patients, 41% received echocardiography after 4 weeks of life, with 37% showing evidence of PH. Logistic regression analysis demonstrated that infants with BPD requiring prolonged PPV, with PH detectable by echocardiogram, were four times more likely to die (adjusted odds ratio): 4.6, 95% confidence interval: 1.3–16.5) when compared with infants with BPD requiring prolonged PPV without echocardiographic evidence of PH.
Conclusion:
Pulmonary hypertension appears to be an important, independent determinant of death in infants with BPD requiring prolonged PPV.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Vohr B, Wright LL, Hack M, Aylward G, Hirtz DE . Follow-up care of high risk infants. Pediatrics 2004; 114: 1377–1397.
Jobe AH, Bancalari E . Bronchopulmonary dysplasia. Am J Respir Crit Care Med 2001; 163: 1723–1729.
Stenmark KR, Abman SH . Lung vascular development: implications for the pathogenesis of bronchopulmonary dysplasia. Annu Rev Physiol 2005; 67: 623–661.
Bush A, Busst CM, Knight WB, Hislop AA, Haworth SG, Shinebourne EA . Changes in pulmonary circulation in severe bronchopulmonary dysplasia. Arch Dis Child 1990; 65: 739–745.
Khemani E, McElhinney DB, Rhein L, Andrade O, Lacro RV, Thomas KC et al. Pulmonary artery hypertension in formerly premature infants with bronchopulmonary dysplasia: clinical features and outcomes in the surfactant era. Pediatrics 2007; 120: 1260–1269.
Fouron JC, Le Guennec JC, Villemant D, Perreault G, Davignon A . Value of echocardiography in assessing the outcome of bronchopulmonary dysplasia of the newborn. Pediatrics 1980; 65: 529–535.
An HS, Bae EJ, Kim GB, Kwon BS, Beak JS, Kim EK et al. Pulmonary hypertension in preterm infants with bronchopulmonary dysplasia. Korean Circ J 2010; 40: 131–136.
Mourani PM, Sontag MK, Younoszai A, Ivy DD, Abman SH . Clinical utility of echocardiography for the diagnosis and management of pulmonary vascular disease in young children with chronic lung disease. Pediatrics 2008; 121: 317–325.
Smith VC, Zupancic JA, McCormick MC, Croen LA, Greene J, Escobar GJ et al. Trends in severe bronchopulmonary dysplasia rates between 1994 and 2002. J Pediatr 2005; 146: 469–473.
Fanaroff AA, Stoll BJ, Wright LL, Carlo WA, Ehrenkranz RA, Stark AR et al. Trends in neonatal morbidity and mortality for very low birth weight infants. Am J Obstet Gynecol 2007; 196: 147.e1–147.e8.
Kinsella J, Greenough A, Abman S . Bronchopulmonary dysplasia. Lancet 2006; 367: 1421–1431.
Hack M, Wright LL, Shankaran S, Tyson JE, Horbar JD, Bauer CR et al. Very-low-birth-weight outcomes of the National Institute of Child Health and Human Development Neonatal Network, November 1989 to October 1990. Am J Obstet Gynecol 1995; 172: 457–464.
Hack M, Horbar J, Malloy M, Wright L, Tyson JE . Very low birth weight outcomes of the National Institute of Child Health and Human Development neonatal network. Pediatrics 1991; 87: 587–597.
Papile L, Burstein J, Burstein R, Koffler H . Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weights less than 1,500 gm. J Pediatr 1978; 92: 529–534.
Walsh MC, Kliegman RM . Necrotizing enterocolitis: treatment based on staging criteria. Pediatr Clin North Am 1986; 33: 179–201.
Mourani PM, Mullen M, Abman SH . Pulmonary hypertension in bronchopulmonary dysplasia. Prog Pediatr Cardiol 2009; 27: 43–48.
Coalson JJ . Pathology of new bronchopulmonary dysplasia. Semin Neonatol 2003; 8: 73–81.
Jobe AH . The new BPD. NeoReviews 2006; 7: e531–e545.
Tang JR, Markham NE, Lin YJ, McMurtry IF, Maxey A, Kinsella JP et al. Inhaled nitric oxide attenuates pulmonary hypertension and improves lung growth in infant rats after neonatal treatment with a VEGF receptor inhibitor. Am J Physiol Lung Cell Mol Physiol 2004; 287: 344–351.
Schmidt AF, Gonçalves FL, Nassr AC, Pereira LA, Farmer D, Sbragia L . Antenatal steroid and tracheal occlusion restore vascular endothelial growth factor receptors in congenital diaphragmatic hernia rat model. Am J Obstet Gynecol 2010; 203: 184.e13–184.e20.
Abman SH . BPD: a vascular hypothesis. Am J Respir Crit Care Med 2001; 164: 1755–1756.
Koch J, Hensley G, Roy L, Brown S, Ramaciotti C, Rosenfeld CR . Prevalence of spontaneous closure of the ductus arteriosus in neonates at a birth weight of 1000 grams or less. Pediatrics 2006; 117: 1113–1121.
McCulloch VA, Tulloh RM . PDA and pulmonary hypertension: should the duct be ligated? [letter]. Arch Dis Child Fetal Neonatal Ed 2010; 95: F75.
Janda S, Shahidi N, Gin K, Swiston J . Diagnostic accuracy of echocardiography for pulmonary hypertension: a systematic review and meta-analysis. Chest 2010; 138: 923A.
Yates AR, Welty SE, Gest AL, Cua CL . Myocardial tissue Doppler changes in patients with bronchopulmonary dysplasia. J Pediatr 2008; 152: 766–770.
Mourani PM, Sontag MK, Ivy DD, Abman SH . Effects of long-term sildenafil treatment for pulmonary hypertension in infants with chronic lung disease. J Pediatr 2009; 154: 379–384.
Kulik TJ, Rhein LM, Mullen MP . Pulmonary arterial hypertension in infants with chronic lung disease: will we ever understand it? J Pediatr 2010; 157: 186–190.
Abman SH . Monitoring cardiovascular function in infants with chronic lung disease of prematurity. Arch Dis Child Fetal Neonatal Ed 2002; 87: F15–F18.
Farquhar M, Fitzgerald DA . Pulmonary hypertension in chronic neonatal lung disease. Paediatr Respir Rev 2010; 11: 149–153.
Acknowledgements
This work was unfunded.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Slaughter, J., Pakrashi, T., Jones, D. et al. Echocardiographic detection of pulmonary hypertension in extremely low birth weight infants with bronchopulmonary dysplasia requiring prolonged positive pressure ventilation. J Perinatol 31, 635–640 (2011). https://doi.org/10.1038/jp.2010.213
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/jp.2010.213
Keywords
This article is cited by
-
Association of the respiratory severity score with bronchopulmonary dysplasia-associated pulmonary hypertension in infants born extremely preterm
Journal of Perinatology (2024)
-
Quantifying side effects and caregiver burdens of pediatric pulmonary hypertension therapies
BMC Pediatrics (2023)
-
Loss of microRNA-30a and sex-specific effects on the neonatal hyperoxic lung injury
Biology of Sex Differences (2023)
-
Preventative practices and effects of the COVID-19 pandemic on caregivers of children with pediatric pulmonary hypertension
BMC Public Health (2022)
-
Risk factors of early pulmonary hypertension and its clinical outcomes in preterm infants: a systematic review and meta-analysis
Scientific Reports (2022)